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Background: Renal artery stent placement is a recognized treatment for patients with hemodynamically significant renal
artery stenosis when medical therapy fails. Duplex ultrasound (DUS) is the primary method used for noninvasive
assessment of renal artery patency. Arterial stents alter the compliance of the artery, which could make the standard
reference values, based on native renal artery velocities, inaccurate. This study attempted to determine DUS criteria for
renal artery in-stent restenosis (ISR).
Methods:We studied 67 consecutive patients with suspected renal artery ISR based on abnormal renal DUS results, defined
as peak systolic velocity (PSV) >200 cm/s and renal/aortic velocity ratio (RAR) >3.5. The ISR patients were compared
with 55 consecutive nonstented patients who underwent renal DUS evaluation and renal angiography. Those with>50%
angiographic narrowing in each group were analyzed, and renal PSV and RAR were compared.
Results: In the 67 patients with renal stents and 55 patients without renal stents, a statistically significant correlation was
found for both PSV and RAR in detecting renal ISR and renal artery stenosis as defined by quantitative angiography (P
.02). For any level of angiographic stenosis>50%, the ISR group had relatively higher PSV and RAR compared with the
nonstented group. Receiver operating characteristic curves indicated that PSV >395 cm/s or RAR >5.1 were the most
predictive of angiographically significant ISR >70%.
Conclusion: The current DUS criteria for native renal arteries may overestimate the degree of angiographic ISR due to
changes in compliance.We recommend that DUS laboratories make adjustments in PSV andRAR obtained byDUSwhen
monitoring the patency of renal stents for ISR. (J Vasc Surg 2009;50:119-23.)Renal artery stent placement is a recognized treatment
for patients with hemodynamically significant renal artery
stenosis when medical therapy fails.1-3 Surgical reconstruc-
tion or bypass is effective, but its use is limited by proce-
dural morbidity and mortality.4,5 In-stent restenosis (ISR)
rates after renal artery stenting range up to 20%.6-14Despite
the need for continuing surveillance for renal artery stent
patency, guidelines for follow-up and noninvasive criteria
for ISR have not been established.
Assessment of ISR after renal stent placement is impor-
tant for the clinical care of patients. Duplex ultrasound
(DUS) imaging of the renal arteries is the primary nonin-
vasive diagnostic method used to detect renal artery steno-
sis15-17 and also has been used to monitor renal artery stent
patency. The current DUS evaluation relies on blood ve-
locity information to predict stenosis in the native (non-
stented) renal arteries; these criteria have been validated by
angiography.16,17 The deployment of a metal stent results
in changes in vessel compliance that affect the velocity of
blood flow, which in turn affects DUS measurements.18
This theory had been studied extensively and confirmed in
the carotid stents.18-20 Because the carotid and renal arter-
ies are similar, both being 6-mm vessels, this concept was
extrapolated to the renal artery stents, which may render
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rate.21,22 The purpose of this study was to provide DUS
criteria for severe renal ISR 70%.
METHODS
Patients. Group I consisted of 67 consecutive patients
with an abnormal renal DUS result, which was defined as
DUS-predicted stenosis 60% after renal stent placement.
These patients were referred for follow-up selective renal
angiography3months of the abnormal renal DUS result.
Group II consisted of 55 consecutive patients during the
same period without renal stent placement. They under-
went a renal DUS evaluation 3 months of a diagnostic
renal angiogram as a part of coronary or peripheral angiog-
raphy, or both.
Ultrasound analysis. Group I patients (renal stents)
had DUS examinations at follow-up intervals of 3, 6, and
12 months and then yearly after their procedures. De novo
baseline DUS results for this group were not available. For
group II patients (native renal arteries without stents), the
index DUS was performed 3 months of the angiogram.
All DUS examinations were performed by registered vascu-
lar technologists in the same vascular laboratory accredited
by the Intersocietal Commission for the Accreditation of
Vascular Laboratories using a Phillips HDI 5000 US ma-
chine (PhillipsMedical Systems, Bothell, Wash) with a 3- to
5-MHz probe according to 2008 vascular professional
performance guidelines established by the Society for Vas-
cular Ultrasound. Velocities in group I were measured at
three locations (proximal, middle, and distal) within the
renal stent as well as distal to the stent. In group II, velocity
measurements of the proximal, middle, and distal artery
119
JOURNAL OF VASCULAR SURGERY
July 2009120 Chi et alwere obtained. The highest measurements of peak systolic
velocity (PSV) and end diastolic velocity (EDV) were re-
corded in both groups. Aortic velocity was taken at the
abdominal aorta at the level of the renal arteries.
The renal/aortic systolic velocity ratio (RAR) for each
group was calculated by dividing the PSV for the respective
group by the aortic PSV for that group. The standard DUS
velocity criteria for 60% stenosis in native renal arteries
(PSV 200 cm/s and RAR 3.5) were used to screen for
renal ISR.16,17 Two grades of stenosis, 0% to 59% and 60%
to 99%, were determined from these criteria. Group I
patients with DUS results showing stenosis 60% were
referred for diagnostic angiography.
Meanwhile, group II patients underwent a baseline
DUS 3 months of a renal angiogram that was performed
as a part of a coronary or peripheral angiographic study, or
both. This DUS information was gathered and analyzed,
and two experienced and certified readers interpreted the
results. Interobserver agreement for the US results was
assessed using  statistics.
Angiographic analysis. By convention, ISR is defined
Fig 1. Scatterplots of the (A) peak systolic velocity (PSV) and (B)
renal/aortic velocity ratio (RAR) correlated to angiographic ste-
nosis. ISR, In-stent restenosis.as a 50% angiographic narrowing within the stent. Selectiverenal angiography using anteroposterior and left anterior
oblique views was performed. The view that demonstrated
the most severe stenosis was used for quantitative measure-
ments using electronic calipers and an automated edge-
detection algorithm.14 The percentage of stenosis was de-
termined by using the minimal luminal diameter (MLD)
divided by the reference vessel diameter (RVD)—the diam-
eter of the nearest normal appearing segment distal to the
stenosis—and expressed as a percentage.14 The same pro-
tocols were used to measure ISR: The percentage of ISR
was determined by using the narrowest stent diameter
(MLD) divided by the normal appearing stent diameter
distal to the ISR (RVD) or the distal normal appearing
native renal artery (RVD). In both groups, only those with
50% angiographic stenosis were included in the final
analysis. Three experienced angiographers performed and
interpreted the angiograms. Interobserver agreement for
the angiographic results was assessed using  statistics.
Statistical analysis. The DUS velocities in groups I
and II were compared. Continuous variables were ex-
pressed as mean  SD. Those with 50% angiographic
narrowing in each group were analyzed, and the DUS
values of renal PSV and RAR of the two groups were
compared using a general linear model to account for the
percentage of stenosis (Minitab Inc, State College, Pa). A
value of P  .05 was accepted as representing a significant
difference. Receiver operating characteristic (ROC) curves
were constructed using PSV and RAR as continuous variables
to determine the DUS parameters with the highest sensitivity
and specificity for detecting angiographic ISR70%.
RESULTS
In group I, which included 67 patients with abnormal
renal DUS results who underwent angiography, 31 (46%)
had an angiographic narrowing of50%. In group II, 30 of
55 patients (55%) had an angiographic narrowing of50%.
For all patients with 50% stenosis by angiography, the
DUS findings in group I (n  31) were compared with
group II (n 30). A statistically significant correlation was
noted for both PSV (P  .02) and RAR (P  .02) in
detecting angiographic renal ISR and renal artery stenosis
(Fig 1). The mean angiographic stenosis was 72% 21% in
group I compared with 70%  20% in group II (P  .66;
Table I. Mean peak systolic velocity and renal/aortic
velocity ratio for 50% angiographic stenosis in both
groups
Group
Mean of those with 50% stenosis
% Stenosis PSV (cm/s) RAR
Group Ia 72  21 452  213 6.00  3.5
Group IIb 70  20 360  153 4.91  2.7
P .66 .002 .020
PSV, peak systolic velocity; RAR, renal/aortic systolic velocity ratio.
aRenal stents with in-stent restenosis.
bNative renal arteries.Table I). The mean PSV in group I was 452 cm/s com-
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RAR in group I was 6.0 compared with 4.9 in group II (P
.02). Both PSV and RAR increased to a greater degree in
the ISR group per percentage of stenosis (Fig 1). In other
words, for any level of angiographic stenosis50%, the ISR
group had higher PSV and RAR values than the nonstented
group (Fig 1).
A good level of interobserver agreement for the angio-
graphic results between the three angiographers was noted
(  .82; P .05). For the DUS interpretations, there was
good interobserver agreement between the two readers
(  .80; P  .05).
The ROC curves associated with the analysis of group
I’s PSV and RAR levels are shown in Figs 2 and 3. These
findings were used to analyze multiple thresholds for PSV
and RAR for accuracy in detecting the degrees of renal ISR.
Independently, a PSV of 395 cm/s yielded a sensitivity of
83%, a specificity of 88%, and an overall accuracy of 87% to
Fig 2. The receiver operating curve of in-stent restenosis peak
systolic velocity for detecting 70% in-stent restenosis in group I.
Fig 3. Receiver operating curve of in-stent restenosis renal/aortic
velocity ratio for detecting 70% in-stent restenosis in group I.predict 70% ISR (Table II). Separately, an RAR of 5.1yielded the highest accuracy rate (88%), with a sensitivity of
94% and a specificity of 86% in detecting70% ISR (Table
III).
DISCUSSION
Renal artery DUS imaging is widely accepted as the
noninvasive test of choice to estimate the severity of renal
artery stenosis. Velocity information—such as the PSV and
RAR—correlates with angiographic stenosis. The practice
of using DUS criteria developed for native renal arteries to
determine stenosis within renal artery stents has not been
studied extensively. Metal stents result in alterations in the
compliance of the vessel wall that reduce vascular compli-
ance and increase the velocity of blood flow.18,21,22 Appro-
priate DUS criteria for ISR are essential to noninvasively
assess the restenosis rate after renal stenting to guide man-
agement and to reduce unnecessary invasive angiography
and its associated costs and morbidity.
Published studies for DUS criteria for renal ISR have
used PSV, RAR, resistive index, or a combination of these
to assess ISR,21-23 whereas others used differences in resis-
tive index,23-26 acceleration time, acceleration index, and
velocity waveform26 to determine the degree of ISR. Bak-
ker et al21 and Napoli et al22 established the usefulness of
DUS for detecting renal ISR when laboratory-specific ve-
locity threshold values were used. Bakker et al21 recom-
mended an increase in PSV from 180 to 226 cm/s and a
lowering of RAR from 3.5 to 2.7 to increase sensitivity and
specificity for ISR. Napoli et al,22 on the other hand,
showed a drop in accuracy in the detection of renal ISR if
the velocity criteria for nonstented renal artery was applied,
and further suggested lowering PSV (from 180 to 144
cm/s) and RAR (from 3.5 to 2.53 ) to increase sensitivity
and specificity to detect ISR.
In two recently published prospective studies, Nolan
et al27 found the current established velocity criteria for
nonstented renal artery (PSV 200 cm/s or RAR 3.5)
were highly predictive of renal ISR. In addition, Rocha-
Singh et al28 in the Renal Artery Stenting with Nonin-
vasive Duplex Ultrasound Follow-up (RENAISSANCE)
trial demonstrated a high concordance rate between
renal artery DUS and angiographic renal ISR using
velocity criteria for nonstented renal arteries (RAR 3.5
or an absolute PSV 225 cm/s).
In our study, renal PSV and RAR were helpful in
determining renal ISR, but both increased to a greater
extent in patients with ISR (group I) than those without
stents (group II). This contrasts with the conclusions of
Bakker et al,21 Nolan et al,27 and Rocha-Singh et al.28
However, the main distinguishing factor in our study com-
pared with the others was the simultaneous comparison of
the renal ISR group (group I) with the nonstented renal
artery stenosis group (group II), as shown in Fig 1. In
addition, the focus of this study was to determine velocity
criteria for severe ISR 70%, which was not the case in
other studies. Although all of the studies agreed on the
usefulness of DUS imaging in detecting renal ISR, the
disagreement lay in the velocity thresholds for PSV and
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should be resolved as more robust prospective trials take
place.
This study demonstrated that for any degree of angio-
graphic stenosis50%, the ISR group had relatively higher
PSV and RAR than those without stents (Fig 1). These
findings are consistent with DUS findings in native and
stented carotid arteries.19,20
A ROC curve for both PSV and RAR in determining
70% angiographic narrowing determined a PSV of 395
cm/s yielded a sensitivity of 83%, a specificity of 88%, and
an overall accuracy of 87% to predict 70% ISR, as noted
earlier. Separately, a RAR of 5.1 yielded the highest accu-
racy rate (88%), with a sensitivity of 94% and a specificity of
86% in detecting70% ISR. Combining PSV and RAR did
not provide additional improvement in diagnostic value
than either parameter alone.
Before reintervention of renal ISR is attempted, one
should consider the clinical parameters—such as worsening
blood pressure control or declining renal function, or
both—in conjunction with the abnormal DUS result and
not act on just the abnormal DUS result alone.
This study has some limitations. Despite being one of
the largest series with renal ISR and DUS velocities re-
ported to date,20,21 this is a single-center, retrospective
cohort study with a relatively small sample size. Additional
flaws include selection bias and the lack of DUS informa-
tion immediately before and after stenting. Therefore,
there is an uncertainty about the ability to generalize our
Table II. Optimal ultrasound-determined peak systolic ve
70% stenosis
Angiographic stenosis Threshold PSV (cm/s) Sensitivity
50%-69%
Group Ia 350 80
Group IIb 285 90
70%
Group Ia 395 83
Group IIb 300 89
NPV, Negative-predictive value; PPV, positive-predictive value; PSV, peak s
aRenal stents with in-stent restenosis.
bNative renal arteries.
Table III. I. Optimal ultrasound-determined renal/aortic
69% and 70% stenosis
Angiographic stenosis Threshold RAR Sensitivity, %
50%-69%
Group Ia 4.1 80
Group IIb 3.6 76
70%
Group Ia 5.1 94
Group IIb 3.7 89
NPV, Negative predictive value; PPV, positive predictive value; RAR, rena
aRenal stents with in-stent restenosis.
bNative renal arteries.results.CONCLUSIONS
The current criteria for DUS-determined renal artery
stenosis, which is based on native (nonstented) renal arter-
ies, may overestimate the degree of angiographic ISR.
Surveillance monitoring for renal stent patency should take
into account that PSV and RAR obtained by DUS are likely
to be higher for any given degree of arterial narrowing
within the stent. In light of the disparities among various
published studies to date, further DUS analysis before and
after stenting in a consecutive series of patients needs to be
performed.
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